Allen Chao, PhD

A lifelong champion for cancer patients and research—and a cancer survivor himself—Dr. Allen Chao is deeply committed to advancing precision medicine. Dr. Chao founded Watson Pharmaceuticals, Inc. (NYSE: WPI) and served as Chairman & CEO from 1985 to 2007, then as Chairman through 2008. He led Watson’s growth through internal R&D, licensing, and mergers and […]

Jeff Sherman, MSCS

Jeff Sherman is Co-Founder and Chief Technology Officer at Zephyr AI, where he leads the architecture of secure, scalable AI and data platforms that help partners match therapies to patients and bring precision medicine to scale. He previously served as Interim CEO of Zephyr AI. Jeff is also a Founding Partner at Red Cell Partners, […]

Lisa Eli, PhD

Lisa Eli, PhD, is Chief Scientific Officer at Zephyr AI, where she leads the company’s translational science, clinical research, and computational biology teams. A recognized leader in precision oncology, Dr. Eli is focused on leveraging AI, multimodal data, and clinical insights to accelerate drug development and advance precision medicine. With more than 20 years of […]